Hyloris Developments SA   Report issue

For profit Phase 3
Founded: Liege Belgium (2013)
Status: No NME R&D (2013)

Organization Overview

First Clinical Trial
2018
NCT03532776
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2018

Timeline

NOW
  • Now

Alternative names

Hyloris Developments | Hyloris Developments SA

Active Ingredients

Drugs in Phase 3 Trials (2)

podofilox (condylox) (1 trial)

tranexamic acid (cyklokapron) (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Condylomata Acuminata (Phase 3)

Warts (Phase 3)

Overview

  • Highest Phase: Phase 3
  • # of Trials: 2
  • # of Trial APIs: 2